For instance, the results for CCR6, being both a gut and brain homing marker, highlight a potential gut-link to a typically CNS-centric disease, as elevated levels of CCR6+ cells have been detected in the CSF of MS patients (8, 9). Here, CCR6 is linked to myeloid sarcoma.